Inhibitors of fibroblast activation protein alpha (FAP) and Prolyl Oligopeptidase (POP) are disclosed, along with their use in various therapies related to conditions, diseases, and disorders involving abnormal cell proliferation such as malignancies and angiogenesis, and in neural disorders such as Alzheimer's disease. Stalk portions of the inhibitor molecules, and substrates of FAP and POP, are also disclosed and may be used, for example, in screening methods for identifying such inhibitors.
本研究公开了成纤维细胞活化蛋白α(FAP)和脯
氨酰寡肽酶(POP)的
抑制剂,以及它们在涉及异常细胞增殖(如恶性肿瘤和血管生成)的条件、疾病和紊乱以及神经紊乱(如阿尔茨海默病)的各种疗法中的用途。此外,还公开了
抑制剂分子的柄部分以及 FAP 和 POP 的底物,例如,可用于识别此类
抑制剂的筛选方法。